|
Milestone Development Services is a consulting company dedicated to connecting
industry needs with innovative technologies and solutions.
Dr. Mike Lee, President of Milestone Development Services, has actively participated
in the growth of new technologies and their integration into drug development.
CPSA Digests
Review abstracts from previous meetings online.
CPSA 2006
Shaping the Pharmaceutical Landscape with Engaged Analytical Sciences
CPSA 2005
Beyond Optimization: Enabling Biology Through Analytical Innovation
CPSA 2004
Integrated Approaches in Drug Discovery & Development:Turning Measurements to Medicine
CPSA 2003
From Proteomics to the Pill: New Initiatives in Proteomics, Drug Discovery, and Development
CPSA 2002
Emerging Standards for Drug Discovery & Development: Perspectives on Technology, Strategy and Relationships
CPSA 2001
New Technologies and Approaches for Increasing Drug Candidate Survivability: Lead Identification to Lead Optimization
|
 |
|
CPSA 2008: The Value Proposition of Analytical Chemistry
|
October 27-30, 2008
Sheraton Bucks County Hotel, Langhorne, Pennsylvania
- Program Chair: Lucinda H. Cohen, Merck Research Laboratories
- Plenary Speaker: David M. Hercules, Vanderbilt University
- Vendor Session Chair: Mark J. Hayward, Lundbeck Research USA
- Poster Session Chairs: Michelle Dennehy, GlaxoSmithKline; James L. Stephenson, RTI International;
Matthew E. Szapacs, GlaxoSmithKline
- Symposia & Roundtables
- Featuring comprehensive perspectives on industry-related issues and needs.
- First-hand experiences with specific applications and technologies are openly discussed.
- Sponsor Hospitality & Evening Workshops
- Lunch & Learn Sessions
- Short Courses:
- Method Development for LC/MS: Traditional Approaches and Emerging Trends
Instructors: Roger Hayes, Schering-Plough Research Institute; Shane Needham, Alturas Analytics
- High Throughput Drug Discovery Support: LC/MS Strategies for Method Development, Profiling and Workflow Solutions
Instructors: Mark Hayward, Lundbeck Research USA; Ken Lewis, OpAns
- Is Poor Bioavailability in Early drug Discovery a Problem and If So, How Can We Solve It?
Instructor: Ayman El-Kattan, Pfizer
- Sample Preparation for Non-Traditional and Traditional Biological Matrices: Mass Spectrometry Quantitation from Organic Molecules to Peptides/Proteins
Instructors: Min Chang, Abbott Laboratories; Qin Ji, Covance
- Keynote Dinner Lectures:
- Distinguished Analytical Scientist Award
- CPSA – Where Technology and Solutions Meet!
|
|
CPSA 2007: Influencing Scientific Decision-Making in Drug Discovery & Development
via Integrated Analytical Sciences and Strategies
|
October 22-25, 2007
Sheraton Bucks County Hotel, Langhorne, Pennsylvania
- Program Chair: Nalini Sadagopan, Pfizer
- Plenary Speaker: Jonathan L. Josephs, Bristol-Myers Squibb
- Keynote Speakers: Liang Li, University of Alberta and
Brad Ackermann, Eli Lilly and Company
- Poster Session Chairs: Jim Stephenson, RTI International and Eric Yang, GlaxoSmithKline
- Vendor Session Chair: Mark Hayward, Lundbeck Research USA
- October 24 - Vendor Session, Social Hour, Exhibition, Keynote Lectures & Dinner held in conjunction with North Jersey ACS
Mass Spectrometry and Delaware Valley Mass Spectrometry Discussion Groups!
|
| Integrated Strategies for Drug Discovery Using Mass Spectrometry |
|
This book provides a thorough and unique review of current analytical approaches,
industry practices, and strategies in drug discovery. The topics represent current
industry benchmarks in specific drug discovery activities that deal with proteomics,
biomarker discovery, metabonomic approaches for toxicity screening, lead
identification, compound libraries, quantitative bioanalytical support,
biotransformation, reactive metabolite characterization, lead optimization,
pharmaceutical property profiling, sample preparation strategies, and automation.
For more information on the book please visit the
Wiley web site
|
| LC/MS Applications in Drug Development |
|
This book is the first to describe LC/MS applications within the context of drug
development - discovery, preclinical, clinical, and manufacturing. A process
overview of drug development from an analytical point of view is provided along
with essential data required to successfully bring a drug to market. In addition
to the thorough technical analysis of LC/MS, this book provides perspective on
the significant changes in strategies for pharmaceutical analysis. The
incorporation of LC/MS is illustrated from target to product.
For more information on the book please visit the
Wiley web site
|
|
overview | training | workshops | consulting | symposia | contact
